Clofarabine for relapsed/refractory LCH and non-LC histiocytosis

Barbara A. Degar, Oussama Abla, Patrick K. Campbell, Alison M. Friedmann, Michael M. Henry, Michelle L. Hermiston, Michael Hogarty, Eric D. Jacobsen, Rima Jubran, Pei-Chi Kao, Victoria B. Koch, Ashish R. Kumar, Stephan Ladisch, Wendy B. London, Kenneth L. McClain, Kimo C. Stine, Birte Wistinghausen, Carlos Rodriguez-Galindo

Open source

DOI: 10.1182/bloodadvances.2026019922
Published: 2026-07-17
Container: Blood Advances
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026019922,
  title = {Clofarabine for relapsed/refractory LCH and non-LC histiocytosis},
  author = {Barbara A. Degar and Oussama Abla and Patrick K. Campbell and Alison M. Friedmann and Michael M. Henry and Michelle L. Hermiston and Michael Hogarty and Eric D. Jacobsen and Rima Jubran and Pei-Chi Kao and Victoria B. Koch and Ashish R. Kumar and Stephan Ladisch and Wendy B. London and Kenneth L. McClain and Kimo C. Stine and Birte Wistinghausen and Carlos Rodriguez-Galindo},
  year = {2026},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2026019922},
  url = {https://doi.org/10.1182/bloodadvances.2026019922}
}

RIS

TY  - JOUR
TI  - Clofarabine for relapsed/refractory LCH and non-LC histiocytosis
AU  - Barbara A. Degar
AU  - Oussama Abla
AU  - Patrick K. Campbell
AU  - Alison M. Friedmann
AU  - Michael M. Henry
AU  - Michelle L. Hermiston
AU  - Michael Hogarty
AU  - Eric D. Jacobsen
AU  - Rima Jubran
AU  - Pei-Chi Kao
AU  - Victoria B. Koch
AU  - Ashish R. Kumar
AU  - Stephan Ladisch
AU  - Wendy B. London
AU  - Kenneth L. McClain
AU  - Kimo C. Stine
AU  - Birte Wistinghausen
AU  - Carlos Rodriguez-Galindo
PY  - 2026
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2026019922
UR  - https://doi.org/10.1182/bloodadvances.2026019922
ER  -

APA

Degar, B. A., Abla, O., Campbell, P. K., Friedmann, A. M., Henry, M. M., Hermiston, M. L., Hogarty, M., Jacobsen, E. D., Jubran, R., Kao, P., Koch, V. B., Kumar, A. R., Ladisch, S., London, W. B., McClain, K. L., Stine, K. C., Wistinghausen, B., & Rodriguez-Galindo, C. (2026). Clofarabine for relapsed/refractory LCH and non-LC histiocytosis. Blood Advances. https://doi.org/10.1182/bloodadvances.2026019922

Source records

crossref · retrieved 2026-09-26T08:16:53.467Z